You are here

hepatitis C

[video]Will These 3 Drugs Keep AbbVie's Future Bright After Humira?

Motley Fool

Wed, 04/30/14 - 08:44 am

Neurocrine Biosciences

Parkinson's Disease

levodopa-carbidopa intestinal gel

At $1,000 A Pill, Hepatitis C Drug Sovaldi Rattles Medicaid Programs

Forbes

Mon, 04/28/14 - 09:20 am

Gilead Sciences

Hepatitis C Space Heats Up

Motley Fool

Sat, 04/26/14 - 10:50 am

Say Hello to the New Fastest Growing Drug in History!

Motley Fool

Wed, 04/23/14 - 12:36 pm

Gilead Sciences

Gilead: X-Marks The Spot For Sovaldi Sales

Seeking Alpha

Wed, 04/23/14 - 10:18 am

Gilead Sciences

Clovis Oncology

Puma Biotechnology

AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C

Yahoo

Tue, 04/22/14 - 09:48 am

Enanta Pharmaceuticals

Will Merck & Co. Inc Unseat Biotech's Hottest Drug?

Motley Fool

Fri, 04/18/14 - 11:42 am

England agrees funding for Gilead hepatitis C drug

Yahoo/Reuters

Thu, 04/17/14 - 12:10 pm

Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides

Motley Fool

Thu, 04/17/14 - 11:49 am

Gilead Sciences

Bristol-Myers Squibb

Express Scripts

Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?

Motley Fool

Tue, 04/15/14 - 10:36 am

Gilead Sciences

Bristol-Myers Squibb

Price of New Hepatitis C Drugs Not So Daunting After All

Bloomberg

Mon, 04/14/14 - 08:35 am

Gilead Sciences

Oncolytics Biotech reports evaluation of clinical study with REOLYSIN

The Fly on the Wall

Mon, 04/14/14 - 08:26 am

Encouraging Data from Bristol-Myers

Yahoo/Zacks

Sat, 04/12/14 - 10:20 am

Bristol-Myers Squibb

AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress

Yahoo/PR NewsWire

Sat, 04/12/14 - 10:15 am

Encouraging Results on Gilead's Sovaldi

Yahoo/Zacks

Sat, 04/12/14 - 10:13 am

Gilead Sciences

Texas Medicaid holds off on proposed limits for Gilead hepatitis drug

Yahoo/Reuters

Fri, 04/11/14 - 03:38 pm

Gilead Sciences

Natco looking to block Indian patent for Gilead's Sovaldi

Fierce Pharma

Fri, 04/11/14 - 11:41 am

Gilead Sciences

Doctors welcome hepatitis C drug rivals, Gilead still leads

Yahoo/Reuters

Fri, 04/11/14 - 08:47 am

Gilead Sciences

Bristol-Myers Squibb

Gilead Sciences: How Big a Threat is Merck?

Barron's

Thu, 04/10/14 - 10:52 am

Gilead Sciences

Merck Data Show Potent Rival to Gilead’s Hepatitis C Pill

Bloomberg

Thu, 04/10/14 - 07:39 am

Pages